EnginZyme
PrivateLast Round
Series B
Dec 19, 2022
Total Funding Raised
$38.14M
Company Overview
EnginZyme is a biotechnology company that develops cell-free synthetic technology to enable sustainable biomanufacturing for the chemical industry.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EnginZyme Comparables
Compare EnginZyme with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zymtronix | 83% | |
| FabricNano | 83% | |
| Enzymicals AG | 80% | |
EnginZyme Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 19, 2022 | ||||
| Series A Extension | Feb 11, 2021 | ||||
| Series A | Apr 21, 2020 | ||||
| Grant | Jan 1, 2020 |
Key People
Founding team and executive leadership
EnginZyme Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bunge Ventures | Series B |
| SEB Group | Series A Extension, Series B |
| Navigare Ventures | Series B |
| Almi Invest AB | Series B |
| Industrifonden | Series B, Series A Extension |
| European Union's Horizon 2020 research and innovation programme (Marie Skłodowska-Curie) | Grant |
| Sofinnova Partners | Series A Extension, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2025
Aymeric de Gantès appointed as the new Chief Executive Officer.
- Dec 19, 2022
$22M round with participation from Bunge Ventures and SEB Group.
EnginZyme Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EnginZyme's valuation, stock price, and market status.